Natural Molecular Announces Comprehensive Women’s Health Testing Services

RENTON, Wash.--()--Natural Molecular Testing Corporation (Natural Molecular) has introduced new diagnostic molecular tests that will help ensure women receive preventive health services issued as part of the enactment of the Affordable Care Act (ACA).

Natural Molecular is a privately owned company providing molecular diagnostic testing services for a number of conditions, including medication metabolism and sensitivity, allowing physicians to better prescribe medication for greater efficacy and safer treatment.

To support improvements in women’s health, Natural Molecular’s cutting-edge diagnostic services include HPV genotyping, sexually transmitted infectious disease testing, cystic fibrosis screening and counseling. Natural Molecular has also partnered with Diagnostic Cytogenetics Inc (DCI) and Puget Sound Institute of Pathology (PSIP) to provide both prenatal and postnatal testing, as well as standard Pap smear and cervical biopsy cancer screening.

Natural Molecular continues to lead in the field of personalized pharmacogenomics testing on acute and chronic medications to guide physicians in medication management and in preventing adverse drug reactions.

“The judicious use of our innovative technology is key to ensuring that all women and girls get access to these important diagnostic services when they need them,” said Michael H. Kalnoski, MD, Laboratory Medical Director of Natural Molecular Testing Corporation.

Natural Molecular’s Chief Executive Officer Beau R. Fessenden believes this is a very important step for Natural Molecular.

“I am very excited about Natural Molecular moving into the area of women’s health. I believe our company can have a great impact in this area, much as we have in the pharmacogenomics arena,” said Fessenden.

About Natural Molecular

Natural Molecular is a privately owned, high-complexity molecular testing facility. Natural Molecular is helping to pioneer personalized medicine testing for our clinical partners to ensure better patient outcomes through the latest breakthroughs in medical technology.

For more information about Natural Molecular Testing Corp., visit www.naturalmolecular.com.

Contacts

Natural Molecular Testing Corporation
Ken Wallace, 425-728-1540
Director of Business Development
or
The Bartlett Group Public Relations
Barry Bartlett, 206-335-4694
barry@bartlettgrouppr.com

Release Summary

Natural Molecular Testing Corporation is introducing new diagnostic molecular tests focusing on preventative health services for women.

Contacts

Natural Molecular Testing Corporation
Ken Wallace, 425-728-1540
Director of Business Development
or
The Bartlett Group Public Relations
Barry Bartlett, 206-335-4694
barry@bartlettgrouppr.com